Back to Search
Start Over
Fitch Affirms Pfizer's IDR at 'A+'; Rating Outlook Stable
- Source :
- Business Wire. April 7, 2016
- Publication Year :
- 2016
-
Abstract
- NEW YORK -- Fitch Ratings has affirmed Pfizer's Long-Term Issuer-Default Rating (IDR) at 'A+' with a Stable Rating Outlook, removing the ratings form Negative Watch. The rating action follows Pfizer, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.448714315